Drug
Delafloxacin
Delafloxacin: highest development phase Phase 3, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Delafloxacin NCT04042077 | Phase 3 | Surgical Site Infection |
Latest
No recent events.
Follow Delafloxacin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.